Synapse Medicine is a leading Medication Intelligence platform that helps saving lives by securing medical prescriptions.
Synapse Medicine is on a mission to provide everyone who needs it with easy access to reliable and up-to-date medical information.
Synapse Medicine was founded in 2017 by Clement Goehrs. The company is headquartered in Bordeaux, France, with an office in San Francisco, California.
Synapse Medicine, via its SaaS platform, offers healthcare professionals such as doctors and pharmacists an easy way to look up reliable, up-to-date information about medications, to analyze prescriptions in real-time, and to ensure the safety of drug therapies.
Synapse has developed the first medication intelligence platform dedicated to correct drug use by collaborating with several major French university hospitals.
Synapse has recently announced several partnerships with top hospitals, such as APHP–Paris (France), the largest hospital in Europe, ranked the eleventh best hospital worldwide, and German hospital La Charité, ranked in sixth place.
Synapse Medicine is backed by Korelya Capital, MACSF, XAnge, BNP Paribas Development, BPI, Nicolas Dessaigne co-founder of Algolia, and others. The company raised $28M in Series B round on Mar 01, 2022. This brings Synapse's total funding to $38.8M to date.